pros and cons to glp 1 Are Weight Loss Medications Right for You? of GLP-1s Are Weight Loss Medications Right
Description
The Effects of Glucagon Like Peptide-1 (GLP-1) on Cardiac Remodelling: Exploring the Role of Medication and Physiological Modulation After Metabolic Surgery: A Narrative Review Minerva Endocrinol (Torino)
Zhang et al., 2023), blood lipids (Wulffel et al., 2004), and cardiovascular risk (Desprs, 2003) associated with T2DM
We look forward to expanding this collaboration to reach more patients and drive better outcomes at scale. Strengthening Access to Authentic Wegovy Through Virtual Care Wegovy is noted as the first GLP-1 therapy approved in the United States for both chronic weight management and cardiovascular risk reduction in adults with obesity
But thats not the only culprit
Stopping these weight loss medications can lead some people to regain weight an average of around 10 pounds in the first year after discontinuing the drug
Stopping might help prevent things from getting worse, but it wont fix whats already happening
